Fresenius SE & Co. KGaA Stock price

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Real-time Estimate Tradegate 07:15:07 2024-03-19 am EDT 5-day change 1st Jan Change
25.04 EUR -0.46% Intraday chart for Fresenius SE & Co. KGaA -1.84% -10.83%
Sales 2024 * 23.05B 25.04B Sales 2025 * 24.09B 26.17B Capitalization 14.17B 15.4B
Net income 2024 * 1.41B 1.53B Net income 2025 * 1.75B 1.9B EV / Sales 2024 * 1.32 x
Net Debt 2024 * 16.32B 17.73B Net Debt 2025 * 15.59B 16.93B EV / Sales 2025 * 1.24 x
P/E ratio 2024 *
10.1 x
P/E ratio 2025 *
7.9 x
Employees 193,865
Yield 2024 *
3.73%
Yield 2025 *
4.21%
Free-Float 73.04%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fresenius SE & Co. KGaA

1 day+0.10%
1 week-1.22%
Current month-2.78%
1 month-4.84%
3 months-9.30%
6 months-16.47%
Current year-10.37%
More quotes
1 week
24.88
Extreme 24.88
25.67
1 month
24.41
Extreme 24.41
27.27
Current year
24.41
Extreme 24.41
29.20
1 year
23.29
Extreme 23.29
31.22
3 years
19.69
Extreme 19.69
47.60
5 years
19.69
Extreme 19.69
52.82
10 years
19.69
Extreme 19.69
80.07
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 21-04-11
Director of Finance/CFO 44 18-12-31
Compliance Officer - 23-07-17
Members of the board TitleAgeSince
Director/Board Member 69 15-05-19
Chairman 69 19-12-31
Director/Board Member 63 16-05-12
More insiders
Date Price Change Volume
24-03-19 25.05 -0.44% 296 278
24-03-18 25.16 +0.64% 714,052
24-03-15 25 -0.71% 2,247,327
24-03-14 25.18 -1.14% 933,882
24-03-13 25.47 -0.12% 1,020,514

Delayed Quote Xetra, March 18, 2024 at 12:35 pm EDT

More quotes
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
25.16 EUR
Average target price
38.21 EUR
Spread / Average Target
+51.85%
Consensus
  1. Stock
  2. Equities
  3. Stock Fresenius SE & Co. KGaA - Xetra